PMID- 12657018 OWN - NLM STAT- MEDLINE DCOM- 20030723 LR - 20190910 IS - 0736-8046 (Print) IS - 0736-8046 (Linking) VI - 20 IP - 2 DP - 2003 Mar-Apr TI - Neonatal lupus erythematosus mimicking langerhans cell histiocytosis. PG - 164-6 AB - Neonatal lupus erythematosus (NLE) is an autoimmune disease characterized primarily by transient skin lesions and/or permanent congenital heart block. Other clinical findings include self-limited cytopenias and liver disease. The syndrome results from the passive transfer of maternal anti-SSA, anti-SSB, or anti-U1RNP autoantibodies to the fetus across the placenta. The cutaneous manifestations are generally analogous to those of subacute cutaneous lupus erythematosus (SCLE) and consist of small, erythematous macules that progress to annular plaques with delicate scaling. The skin lesions usually resolve within the first 6 months of life as maternal autoantibodies are cleared from the infant's circulation. We describe a patient with cutaneous NLE with hepatic and hematologic manifestations. The clinical presentation was atypical, with splenomegaly and petechiae at birth followed by a crusting, papulosquamous skin eruption of the scalp and face mimicking Langerhans cell histiocytosis (LCH). FAU - Scheker, Luis Emilio AU - Scheker LE AD - Division of Dermatology, Department of Medicine, University of Louisville School of Medicine, Kentucky 40202, USA. FAU - Kasteler, J Scott AU - Kasteler JS FAU - Callen, Jeffrey P AU - Callen JP LA - eng PT - Case Reports PT - Journal Article PL - United States TA - Pediatr Dermatol JT - Pediatric dermatology JID - 8406799 RN - 0 (Antibodies, Antinuclear) RN - 0 (Autoantibodies) SB - IM MH - Antibodies, Antinuclear/analysis MH - Autoantibodies/analysis MH - Biopsy, Needle MH - Diagnosis, Differential MH - Facial Dermatoses/diagnosis MH - Female MH - Follow-Up Studies MH - Histiocytosis, Langerhans-Cell/*diagnosis MH - Humans MH - Immunohistochemistry MH - Infant, Newborn MH - Lupus Erythematosus, Cutaneous/*diagnosis/*genetics MH - Pedigree MH - Risk Assessment MH - Severity of Illness Index EDAT- 2003/03/27 05:00 MHDA- 2003/07/24 05:00 CRDT- 2003/03/27 05:00 PHST- 2003/03/27 05:00 [pubmed] PHST- 2003/07/24 05:00 [medline] PHST- 2003/03/27 05:00 [entrez] AID - 20216 [pii] AID - 10.1046/j.1525-1470.2003.20216.x [doi] PST - ppublish SO - Pediatr Dermatol. 2003 Mar-Apr;20(2):164-6. doi: 10.1046/j.1525-1470.2003.20216.x.